Malignant Hepatobiliary Neoplasm — Research

Malignant Hepatobiliary Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-11	432	`("Malignant Hepatobiliary Neoplasm"[tiab] OR "Hepatobiliary Cancer"[tiab] OR "Liver/hepatobiliary cancer"[tiab] OR "Liver and hepatobiliary cancer, NOS"[tiab] OR "Malignant Liver and Biliary Neoplasm"[tiab] OR "Malignant Liver and Biliary Tract Neoplasm"[tiab] OR "Malignant Liver and Biliary System Neoplasm"[tiab])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	210	`("Malignant Hepatobiliary Neoplasm"[tiab] OR "Hepatobiliary Cancer"[tiab] OR "Liver/hepatobiliary cancer"[tiab] OR "Liver and hepatobiliary cancer, NOS"[tiab] OR "Malignant Liver and Biliary Neoplasm"[tiab] OR "Malignant Liver and Biliary Tract Neoplasm"[tiab] OR "Malignant Liver and Biliary System Neoplasm"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	39	`("Malignant Hepatobiliary Neoplasm"[tiab] OR "Hepatobiliary Cancer"[tiab] OR "Liver/hepatobiliary cancer"[tiab] OR "Liver and hepatobiliary cancer, NOS"[tiab] OR "Malignant Liver and Biliary Neoplasm"[tiab] OR "Malignant Liver and Biliary Tract Neoplasm"[tiab] OR "Malignant Liver and Biliary System Neoplasm"[tiab]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 20 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (127)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 76–100 of 127 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study.
· Lancet Gastroenterol Hepatol · 2021 · PMID 34358484 · validated civic_curation pubmed
DNAJB1-PRKACA is specific for fibrolamellar carcinoma.
· Mod Pathol · 2015 · PMID 25698061 · validated civic_curation pubmed
Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.
· Science · 2014 · PMID 24578576 · validated civic_curation pubmed
Unique genomic profile of fibrolamellar hepatocellular carcinoma.